StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Earnings

Abeona Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 16, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$13.50M
EPS, Q3 FY2026
-$0.08
-$0.10 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Abeona Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open$13.50M–-$0.08Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$11.40M+2750.0%-$0.35Release
Q1 FY2026ended Mar 31, 2026May 13, 2026before the open$8.70M–-$0.30Release
Q4 FY2025ended Dec 31, 2025Mar 17, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open––-$0.10Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$400.00K–$1.71Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open––-$0.24Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024before the open––-$0.63Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open––-$0.26Release
Q1 FY2024ended Mar 31, 2024May 15, 2024before the open––-$1.16Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Abeona Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Abeona Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Abeona Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Update
  6. Results
  7. Update
  8. Results
  9. Results
  10. Update
  11. Results
  12. News
  13. Results
  14. Results
  15. Results

See a number that looks wrong?